Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-21-006005
Filing Date
2021-11-29
Accepted
2021-11-29 16:14:30
Documents
64
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 cannabics_10k-083121.htm 10-K 708194
2 CERTIFICATION cannabics_10k-ex3101.htm EX-31.1 11235
3 CERTIFICATION cannabics_10k-ex3102.htm EX-31.2 11435
4 CERTIFICATION cannabics_10k-ex3201.htm EX-32.1 4286
5 CERTIFICATION cannabics_10k-ex3202.htm EX-32.2 4493
6 FORM OF AUDIT COMMITTEE CHARTER cannabics_10k-ex9901.htm EX-99.1 43521
7 FORM OF COMPENSATION COMMITTEE CHARTER cannabics_10k-ex9902.htm EX-99.2 23327
14 GRAPHIC image_001.jpg GRAPHIC 17220
15 GRAPHIC image_002.jpg GRAPHIC 15785
16 GRAPHIC image_003.jpg GRAPHIC 51045
17 GRAPHIC image_004.jpg GRAPHIC 31810
18 GRAPHIC image_005.jpg GRAPHIC 33078
19 GRAPHIC image_006.jpg GRAPHIC 46783
20 GRAPHIC image_007.jpg GRAPHIC 5806
21 GRAPHIC image_008.jpg GRAPHIC 44572
22 GRAPHIC image_013.jpg GRAPHIC 7896
23 GRAPHIC image_014.jpg GRAPHIC 2232
24 GRAPHIC image_015.jpg GRAPHIC 25252
  Complete submission text file 0001683168-21-006005.txt   2831858

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE cnbx-20210831.xml EX-101.INS 266845
9 XBRL SCHEMA FILE cnbx-20210831.xsd EX-101.SCH 24008
10 XBRL CALCULATION FILE cnbx-20210831_cal.xml EX-101.CAL 36501
11 XBRL DEFINITION FILE cnbx-20210831_def.xml EX-101.DEF 68045
12 XBRL LABEL FILE cnbx-20210831_lab.xml EX-101.LAB 175516
13 XBRL PRESENTATION FILE cnbx-20210831_pre.xml EX-101.PRE 139828
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 211456297
SIC: 2834 Pharmaceutical Preparations